• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Michael Rosenblatt - Articles and news items

Merck logo

Merck statement regarding CHMP review of incretin-based therapies for type 2 diabetes, including sitagliptin

Industry news, News / 26 July 2013 / Merck

“Nothing is more important to us than the safety of our medicines…”

Merck logo

Merck welcomes independent review of the safety profile of JANUVIA® (sitagliptin)

Industry news, News / 12 June 2013 / Merck

“Nothing is more important to Merck than the safety of our medicines…”

Merck logo

Merck provides update on next steps for TREDAPTIVE™ (extended-release niacin/laropiprant)

Industry news, News / 11 January 2013 / Merck

Merck is taking steps to suspend the availability of TREDAPTIVE™ tablets worldwide…

Merck logo

Merck statement on voluntary submission of clinical research protocols

Industry news, News / 1 July 2011 / Merck

For its investigational and approved products…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +